US, Europe, Japan Drug of Abuse & Endocrine Function Testing Market Emerging Opportunities 2013

During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

2013 Analysis of the Drug of Abuse Testing Market

“Drugs of Abuse Testing Market: US, Europe, Japan” is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.

Request a Sample Copy Drug of Abuse Testing Market @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=90209

2013 Analysis of the Endocrine Function Testing Market

“Endocrine Function Diagnostics Market: US, Europe, Japan” is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.

Request a Sample Copy Endocrine Function Testing Market @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=90210

Table of Content

Introduction

Worldwide Market and Technology Overview

A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants

A. Major Endocrine Function Tests
1. Cortisol
2. Follicle-Stimulating Hormone (FSH)
3. Gastrin
4. Growth Hormone/IGF-1
5. Human Chorionic Gonadotropin (HCG)
6. LH
7. PTH/IO PTH
8. Prolactin
9. T3
10. T3 Free
11. T3 Uptake
12. T4 (Thyroxine)
13. T4 Free
14. TBG
15. Thyroglobulin Ab
16. TPO Ab
17. TSH

B. Instrumentation Review: Operating Characteristics and Features of High-, Medium-, and LowVolume/POC Analyzers Manufactured By:
Abaxis
Abbott
Alere/Inverness
Alfa Wassermann
AMS
Awareness Technologies
Beckman Coulter/Olympus
Binding Site
bioMerieux
Carolina Chemistries
DiaSorin
Grifols
Horiba
Medica
Nova Biomedical
Ortho-Clinical Diagnostics
Polymedco
Randox
Roche
Siemens
Tosoh
Vital Diagnostics

C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

France: Test Volume and Sales Forecasts

Germany: Test Volume and Sales Forecasts

Italy: Test Volume and Sales Forecasts

Japan: Test Volume and Sales Forecasts

Spain: Test Volume and Sales Forecasts

U.K.: Test Volume and Sales Forecasts

U.S.A.: Test Volume and Sales Forecasts

Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

Competitive Assessments
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory

For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441

Website: http://www.rnrmarketresearch.com/